vTv Therapeutics Inc

VTVT

Company Profile

  • Business description

    vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.

  • Contact

    3980 Premier Drive
    Suite 310
    High PointNC27265
    USA

    T: +1 336 841-0300

    E: [email protected]

    https://www.vtvtherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    23

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,445.9080.200.96%
CAC 407,593.8738.000.50%
DAX 4022,496.9871.150.32%
Dow JONES (US)40,752.9683.600.21%
FTSE 1008,496.801.950.02%
HKSE22,491.94372.531.68%
NASDAQ17,710.74264.401.52%
Nikkei 22536,883.12430.821.18%
NZX 50 Index12,327.89179.291.48%
S&P 5005,604.1435.080.63%
S&P/ASX 2008,228.2082.601.01%
SSE Composite Index3,279.037.62-0.23%

Market Movers